Author

Maïté Verreault

Centre National de la Recherche ScientifiqueORCID 0000-0001-6708-7698Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:deep learning· 2 Approach:statistical model· 2 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Ahmed IdbaïhiD· 3 shared Agustí AlentorniD· 1 shared Alice LaurengeiD· 1 shared Annabelle BallestaiD· 1 shared Antonio IavaroneiD· 1 shared Aurore DesmonsiD· 1 shared Bertrand MathoniD· 1 shared Camille Labadie· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Ahmed IdbaïhORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyActa Neuropathologica CommunicationsPeer-reviewedJul 20, 2026

Multi-omics characterization of IDH-mutant astrocytoma-derived cell lines reveals NOTCH-regulated plastic quiescent astrocyte-like state

Leonor Garcia, Christine Granotier, Donovan Pineau…·Jean‐Philippe Hugnot

The paper establishes and characterizes IDH-mutant astrocytoma cell lines, revealing NOTCH-regulated plasticity between astrocyte-like and oligodendrocyte-like states.

DOI 10.1186/s40478-026-02316-9

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyBritish Journal of PharmacologyPeer-reviewedApr 14, 2025

Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by quantitative systems pharmacology and machine learning

Sergio Corridore, Maïté Verreault, Hugo Martin…·Annabelle Ballesta

5 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 23, 2024

Oncometabolite-driven enhancer hypermethylation promotes a hyporesponsive microglial state in IDH-mutant gliomas

Alice Laurenge, Pietro Pugliese, Sarah Scuderi…·Luis Jaime Castro‐Vega

This study shows that oncometabolite D-2HG drives enhancer hypermethylation in IDH-mutant gliomas, leading to hyporesponsive microglia and reduced immune reactivity.

3 citations

humanDNA methylation

𝕏 PostBluesky